Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Total 13F shares
-
46,298,815
-
Share change
-
-859,620
-
Total reported value
-
$5,194,961,361
-
Put/Call ratio
-
47%
-
Price per share
-
$112.26
-
Number of holders
-
345
-
Value change
-
-$89,035,927
-
Number of buys
-
167
-
Number of sells
-
143
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q2 2018
As of 30 Jun 2018,
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) was held by
345 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,298,815 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., FIL Ltd, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, AQR CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, ARIEL INVESTMENTS, LLC, WELLS FARGO & COMPANY/MN, FMR LLC, and STATE STREET CORP.
This page lists
345
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.